PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBS.L Regulatory News (SBS)

  • There is currently no data for SBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Source Bioscience Plc

25 Aug 2016 09:44

RNS Number : 1344I
Nplus1 Singer Capital Markets Ltd
25 August 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Source Bioscience Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Source Bioscience Plc

(d) Date dealing undertaken:

24 August 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 2P

 

Purchase

 

1,300

 

17.8811p

 

17.8811p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

25 August 2016

Contact name:

Reema Maru

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKPDQFBKKNFB
Date   Source Headline
15th Sep 20163:49 pmRNSScheme Effective / Unlisted Securities Alternative
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) Source BioScience plc
15th Sep 20168:30 amRNSAMENDMENT - Form 8 (DD) - Source BioScience plc
14th Sep 20164:45 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:42 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:40 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 20164:38 pmRNSForm 8 (DD) - Source BioScience plc
14th Sep 201611:29 amRNSDirector/PDMR Shareholding
13th Sep 20163:23 pmRNSAdditional Listing on Exercise of Share Options
13th Sep 20163:19 pmRNSScheme becomes Effective: Announcement error
13th Sep 20162:25 pmRNSCourt Sanction of the Scheme
13th Sep 20161:00 pmRNSScheme of arrangement becomes Effective
13th Sep 201612:04 pmRNSForm 8.3 - Source BioScience plc
13th Sep 20169:49 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
9th Sep 20164:17 pmRNSResults of Court Meeting and General Meeting
7th Sep 201610:55 amRNSRule 2.10 Announcement
6th Sep 20162:19 pmRNSForm 8.5 (EPT/RI) - Source Bioscience
6th Sep 201612:03 pmRNSAdditional Listing
6th Sep 201610:27 amRNSForm 8.5 (EPT/RI) - Source Bioscience
5th Sep 201610:11 amRNSForm 8.3 - Source BioScience plc
2nd Sep 201612:09 pmRNSForm 8.3 - Source BioScience plc
1st Sep 20161:20 pmRNSForm 8.3 - Source BioScience plc
31st Aug 201611:44 amRNSForm 8.3 - Source BioScience plc
30th Aug 20161:18 pmRNSForm 8.3 - Source BioScience plc
26th Aug 201612:57 pmRNSForm 8.3 - Source BioScience plc
26th Aug 20169:38 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
25th Aug 20162:30 pmRNSForm 8.3 - Source BioScience plc - Amendment
25th Aug 20169:44 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
24th Aug 201611:59 amRNSForm 8.3 - Source BioScience plc
24th Aug 20169:40 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
23rd Aug 20169:56 amRNSForm 8.5 (EPT/RI) - Source Bioscience
19th Aug 201610:19 amRNSForm 8.3 - Source BioScience plc
19th Aug 20169:53 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
18th Aug 20162:35 pmRNSForm 8.3 - Source BioScience plc
18th Aug 20167:00 amRNSPosting of Scheme Document
17th Aug 201610:49 amRNSForm 8.3 - Source BioScience plc
16th Aug 20162:10 pmRNSForm 8.3 - Source BioScience plc
15th Aug 20161:52 pmRNSForm 8.3 - Source BioScience plc
12th Aug 20169:33 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
12th Aug 20167:00 amRNSForm 8.3 - Source BioScience plc
11th Aug 20162:14 pmRNSForm 8.3 - Source BioScience plc
11th Aug 20169:24 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
10th Aug 20169:22 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
9th Aug 20164:02 pmRNSForm 8.3 - Source BioScience plc
9th Aug 20169:21 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
8th Aug 20162:14 pmRNSForm 8.3 - Source BioScience plc
8th Aug 20169:36 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
5th Aug 20161:56 pmRNSForm 8.3 - Source BioScience plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.